论文部分内容阅读
在经典的鞣化羊红细胞电泳试验(TEEM)的基础上,我们发现癌患者血清能直接诱使鞣化羊红细胞(TSRBC)电泳迁移减慢,而非癌症患者及正常人血清则很少或缺乏此种效应。本文报道了以TEEM试验测试八种恶性肿瘤的结果。在237例癌患者血清样品中,TEEM阳性反应者达90％以上。我们还从癌患者血清中分离和部份纯化出一种分子量介于50,000～70,000道尔顿的致缓因子。由于多种癌患者血清均具有TEEM反应,故初步推断,癌患者血清可能存在一种共同的肿瘤标志物。目前尚在进一步研究之中。
On the basis of the classic TEEM, we found that the sera of cancer patients can directly induce slow migration of TRBC electrophoresis, while the serum of non-cancer patients and normal people has little or no serum. This effect. This article reports the results of testing eight malignant tumors with the TEEM test. In the serum samples of 237 cancer patients, more than 90% of TEEM-positive responders were present. We also isolated and partially purified a mitigating factor with a molecular weight between 50,000 and 70,000 daltons from the serum of cancer patients. Since the serum of many cancer patients has TEEM response, it is presumed that there may be a common tumor marker in cancer patients. It is still under further study.